logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda | Journal Article / Commentary | MSF Science Portal
Journal Article
|Commentary

Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda

Mills EJ, Bakanda C, Birungi J, Mwesigwa R, Chan KN, Ford NP, Hogg RS, Cooper C
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
Evaluations of CD4 cell count and other prognostic factors on the survival of HIV patients in sub-Saharan Africa are extremely limited. Funders have been reticent to recommend earlier initiation of treatment. We aimed to examine the effect of baseline CD4 cell count on mortality using data from HIV patients receiving combination antiretroviral therapy (cART) in Uganda.

Countries

Uganda

Subject Area

HIV/AIDS

Languages

English
DOI
10.1097/QAD.0b013e32834564e9
Published Date
27 Mar 2011
PubMed ID
21330903
Journal
AIDS
Volume | Issue | Pages
Volume 25, Issue 6
Issue Date
2011-03-27
Dimensions Badge